BPL-003 Efficacy and Safety in Treatment Resistant Depression
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study randomized, quadruple masked, multi-center study designed to
investigate the efficacy and safety of a single dose of BPL-003 combined with psychological
support in patients with treatment resistant depression (TRD).